Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX6LQU
|
||||
Drug Name |
4-(4-Benzoyl-piperidin-1-yl)-4-(R)-oxo-3-(3-m-tolyl-ureido)-butyric acid benzyl ester
|
||||
Synonyms |
CHEMBL105404
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C31H33N3O5
|
||||
Canonical SMILES |
Cc1cccc(NC(=O)N[C@H](CC(=O)OCc2ccccc2)C(=O)N3CCC(CC3)C(=O)c4ccccc4)c1
|
||||
InChI |
InChI=1S/C31H33N3O5/c1-22-9-8-14-26(19-22)32-31(38)33-27(20-28(35)39-21-23-10-4-2-5-11-23)30(37)34-17-15-25(16-18-34)29(36)24-12-6-3-7-13-24/h2-14,19,25,27H,15-18,20-21H2,1H3,(H2,32,33,38)/t27-/m1/s1
|
||||
InChIKey |
CMYMFJIRDMYHDJ-HHHXNRCGSA-N
|
||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1587926] | ||
Cholecystokinin receptor type A | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.